|
Feb 7
|
Super Bowl Ads Will Be High on AI, Low on Politics
|
|
Feb 4
|
Hims & Hers Launches Health Collective and Community Member Council
|
|
Feb 3
|
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
|
|
Feb 3
|
February 2025 US Stocks That May Be Trading Below Estimated Value
|
|
Jan 24
|
3 US Growth Companies With 17% Insider Ownership
|
|
Dec 19
|
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List
|
|
Dec 19
|
Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls
|
|
Dec 19
|
FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next
|
|
Dec 17
|
Tesla, crypto miners, Hims & Hers Health: Trending Tickers
|
|
Oct 29
|
How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
|
|
Oct 27
|
Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage
|
|
Oct 17
|
3 US Growth Companies With Significant Insider Ownership
|
|
Oct 16
|
Hims & Hers Shares Rallied 22% Over Two Days. Why That Move Is Now At Risk.
|
|
Oct 15
|
Walgreens closing 1,200 stores over next 3 years, 800 more under evaluation
|
|
Oct 15
|
Do Its Financials Have Any Role To Play In Driving Hims & Hers Health, Inc.'s (NYSE:HIMS) Stock Up Recently?
|
|
Oct 14
|
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
|
|
Oct 14
|
Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
|
|
Oct 14
|
Hims & Hers surges as FDA mulls over compounded drugs limit
|
|
Oct 10
|
WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'
|
|
Oct 4
|
Hims & Hers Health Set to Join S&P SmallCap 600
|